Choriogonadotropin alfa
- Generic Name
- Choriogonadotropin alfa
- Brand Names
- Ovidrel, Ovitrelle, Pregnyl
- Drug Type
- Biotech
- CAS Number
- 177073-44-8
- Unique Ingredient Identifier
- 6413W06WR3
- Background
Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH.
- Indication
For the treatment of female infertility
- Associated Conditions
- Secondary Hypogonadotrophic hypogonadism
- Associated Therapies
- Assisted Reproductive Technology therapy, Ovulation induction therapy
Breakthrough in Infertility Treatment: rhFSH-CTP Shows Promise in Clinical Trials
A novel long-acting recombinant human follicle-stimulating hormone, rhFSH-CTP, has demonstrated significant potential in improving infertility treatment outcomes. Clinical trials reveal that rhFSH-CTP can reduce the number of required injections, enhance patient compliance, and maintain therapeutic efficacy, marking a significant advancement in assisted reproductive technologies.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath